partial dopamine/5-HT receptor ligands (A2M Pharma/Synovo)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namepartial dopamine/5-HT receptor ligands (A2M Pharma/Synovo)
Drug Alias Namepartial dopamine/5-HT receptor ligands (A2M Pharma)partial dopamine/5-HT receptor ligands (A2M Pharma/Synovo)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor agonistsDopamine receptors agonists
TargetsDopamine receptorsSerotonin (5-HT) receptor
Therapy Area/IndicationsSchizophreniaMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUcb Pharma Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesA2M Pharma GmbHSynovoUcb Pharma Gmbh
Active IndicationsN/A
Inactive IndicationsSchizophreniaMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A